Prospects of Non-Coding Elements in Genomic DNA Based Gene Therapy

Area of Science:

• Molecular Medicine
• Genetics
• Biotechnology

Background:

• Gene therapy research has progressed significantly over decades, overcoming challenges like immune responses and insertional mutagenesis.
• Advances in next-generation sequencing (NGS) and nanotechnology underscore the importance of non-coding genomic regions.

Purpose of the Study:

• To summarize the significance of non-coding genomic elements in gene therapy.
• To highlight the advantages of utilizing full-length genomic DNA (gDNA) loci compared to current complementary DNA (cDNA) or minigene approaches.

Main Methods:

• Literature review focusing on non-coding DNA elements in gene therapy.
• Comparative analysis of gDNA loci, cDNA, and minigenes for therapeutic applications.

Main Results:

• Non-coding genomic segments play a crucial role in advancing gene therapy.
• Full-length gDNA loci offer distinct advantages over cDNA and minigenes for gene therapy applications.

Conclusions:

• Genomic DNA (gDNA) loci represent a promising frontier for gene therapy, expanding therapeutic options in molecular medicine.
• The strategic use of gDNA holds potential to overcome existing limitations and enhance the efficacy of gene-based treatments.